Patients currently prescribed cilazapril + hydrochlorothiazide...
March 2020
Patients taking oral flecainide or amiodarone need to know that...
July 2019
The benefits of intentional weight loss in people who are overweight...
May 2019
In February 2018, the Ministry of Health released the Cardiovascular...
November 2018
The Cardiovascular Disease Risk Assessment and Management for...
October 2018
Prescribers in New Zealand are highly reliant on cilazapril...
September 2018
The recently released Cardiovascular Disease Risk Assessment...
August 2018
These guidelines have been produced by PHARMAC in conjunction...
July 2018
From 1 August, 2018, rivaroxaban will be fully subsidised without...
July 2018
The recently released 2018 Cardiovascular Disease Risk Assessment...
May 2018
An increasing incidence of early onset type 2 diabetes in New...
May 2018
Lowering lipid levels should be viewed as one aspect of reducing...
September 2017
There is much debate as to whether intensive blood pressure...
August 2017
Most patients with atrial fibrillation can be managed in primary...
August 2017
Patients taking oral anticoagulants require appropriate management...
August 2017
Metoprolol succinate accounts for almost three-quarters of the...
July 2017
A recently published study from the University of Otago provides...
October 2016
The funded brand of amiodarone has now changed, see: Antiarrhythmic...
October 2016
Out-of-clinic blood pressure monitoring is increasingly regarded...
May 2016
The management of type 2 diabetes is multi-faceted. Following...
December 2015
In the previous edition of Best Practice Journal, we covered...
September 2015
The article: "The immediate management of acute coronary syndromes...
August 2015
Infective endocarditis is a relatively rare infection of the...
June 2015
The majority of patients who present to general practice with...
April 2015
Antithrombotic medicines, such as aspirin and warfarin, have...
April 2015
Brand changes for cardiovascular medicines: carvedilol, ezetimibe...
April 2015
This report provides an update on the use and monitoring of...
March 2015
In 2014 we published over 60 medical education articles in Best...
February 2015
A more recent article has been published on this subject: Weight...
December 2014
This article has been archived.
If you would like access...
October 2014
Statins are one of the most frequently prescribed medicines...
October 2014
Does aspirin protect against cancer? More high-quality research...
September 2014
Calculating a patient’s cardiovascular risk is relatively easy;...
September 2014
Muscle pain (myalgia) and weakness is experienced by up to 10%...
August 2014
Calculating a patient’s ankle-brachial pressure index (ABPI)...
April 2014
2013 began with publication of the 50th issue of Best Practice...
February 2014
A growing body of evidence and expert opinion suggests that...
November 2013
Hypertension is associated with a wide-range of cardiovascular...
August 2013
Ticagrelor (Brilinta) is a new oral antiplatelet medicine, which...
August 2013
Giant cell arteritis, also referred to as temporal arteritis,...
June 2013
THERE HAVE BEEN RECENT REPORTS in the literature associating...
April 2013
Heart failure is now described as either heart failure with...
February 2013
Once heart failure has been diagnosed, the goal of treatment...
February 2013
Dabigatran has been available for general practitioners to prescribe...
February 2013
This A4 printable patient information sheet is designed to help...
December 2012
Cardiovascular risk assessment tools automatically adjust risk...
September 2012
New Zealand is one of the most overweight countries in the world....
August 2012
This report highlights four key prescribing and laboratory testing...
March 2012
Consideration of laboratory testing and interpretation of subsequent...
March 2012
The PHO Performance Programme was established in 2005 to improve...
December 2011
The dabigatran data sheet was updated in early November 2011...
December 2011
In July 2011, a consensus forum was held in Wellington to discuss...
October 2011
A transient ischaemic attack (TIA) is a medical emergency due...
October 2011
This web version is a sample only, all data below the national...
October 2011
Atrial fibrillation (AF) is often an incidental finding during...
October 2011
Patients presenting with symptoms consistent with angina is...
October 2011
• New maternity referral guidelines released
• Simvastatin:...
September 2011
Dabigatran (Pradaxa) is now available in New Zealand, fully...
September 2011
Raynaud's phenomenon is a circulatory disorder, characterised...
August 2011
In New Zealand, acute rheumatic fever is now almost exclusively...
August 2011
Counties Manukau DHB Māori Gout Action Group have identified...
August 2011
The PHO Performance Programme is a quality improvement initiative...
August 2011
Dabigatran to be listed | Most broad spectrum antibiotics do...
June 2011
CRP alone is the best test for temporal arteritis.
This...
March 2011
Despite much being known about cardiovascular risk assessment,...
December 2010
New Zealand continues to have high rates of rheumatic fever,...
November 2010
Ask a Pacific person what a healthy lifestyle means for them...
November 2010
This article has been archived.
If you would like access...
November 2010
This article has been archived.
If you would like access...
October 2010
Evidence suggests that warfarin is under utilised in older people....
October 2010
Once the decision has been made to initiate antihypertensive...
October 2010
This article has been archived.
If you would like access...
October 2010
The decision to initiate a statin should be based upon an individual’s...
August 2010
Maintaining good glycaemic control reduces the risk of microvascular...
August 2010
This article has been archived.
If you would like access...
August 2010
A more recent article has been published on this subject: Weight...
April 2010
The aim of stroke rehabilitation is for the patient to regain...
April 2010
People who have had a stroke or transient ischaemic attack are...
March 2010
Stroke is the third most common cause of death in New Zealand,...
March 2010
New Zealanders are getting fatter. That’s a fact. When a problem...
December 2009
Should aspirin still be used for primary prevention of cardiovascular...
December 2009
Troponins have overtaken the traditional ‘cardiac enzymes’,...
December 2009
Nicotinic acid/laropiprant (Tredaptive) ▪ Fosamax Plus...
November 2009
Enoxaparin (Clexane) is a low molecular weight heparin used...
November 2009
Mate tākihi ukiuki
Chronic kidney disease affects approximately...
July 2009
He manawa takitahi, he iwi takitini
“One Heart Many Lives”...
July 2009
The New Zealand Guidelines Group recently released their updated...
June 2009
Monitoring a person on diuretics is necessary to assess response...
March 2009
The decision whether to choose aspirin or warfarin for stroke...
February 2009
For one in four people, transient ischaemic attack (TIA) is...
February 2009
Antiplatelet drugs including aspirin, clopidogrel and dipyrimadole,...
February 2009
Anaphylaxis is a potentially fatal hypersensitivity reaction,...
December 2008
When advice is provided to patients about reducing cardiovascular...
December 2008
Debate about the clinical usefulness of a diagnosis of metabolic...
December 2008
Once a patient understands their CVD risk, the next step is...
October 2008
Many GPs find it difficult to explain CVD risk to their patients....
October 2008
New PHO Performance indicators announced.
GPs experiences of...
October 2008
A summary of the findings of a recent study which raises questions...
October 2008
Professor Rod Jackson and Professor Simon Capewell debate screening...
October 2008
Cardiovascular disease and type II diabetes are major causes...
May 2008
Creating a cardiovascular risk assessment alert in your PMS.
May 2008
Older people have a higher cardiovascular risk and therefore...
February 2008
• Calcium Supplementation and the risk of myocardial infarction
• Use...
December 2007
Thiazides are considered to be appropriate initial treatment...
December 2007
“Would you like fries with that”. The role of co-enzyme...
September 2007
Carvedilol may be an option for patients initiating beta-blocker...
September 2007
Can Sumatriptan be used safely with SSRIs?
Can you ever use...
August 2007
What is the significance of the warning between ACE inhibitors...
June 2007
Recent literature has raised doubts about the role of β-blockers...
June 2007
Warfarin has the potential to interact with numerous drugs resulting...
April 2007
Stroke is the third leading cause of death in New Zealand, after...
April 2007
Can smoking cessation affect the dose of antipsychotics?Do statins...
February 2007
Reducing adverse events in patients taking amiodarone.
December 2006
An update on treatment of atrial fibrillation with a focus on...
December 2006
Is it safe to use beta-blockers for cardiac disease in people...
October 2006
Cardiovascular risk associated with NSAIDs and coxibsNSAIDs...
October 2006
The purpose of the PHO Performance Programme is to reduce disparities...
June 2011